Open heart surgery after renal transplantation

Asian Cardiovasc Thorac Ann. 2014 Sep;22(7):775-80. doi: 10.1177/0218492313507784. Epub 2013 Oct 3.

Abstract

Aim: to evaluate the strategy for open heart surgery after renal transplantation performed in a single institution in Japan.

Methods: we reviewed 6 open heart surgeries after renal transplantation in 5 patients, performed between January 1992 and December 2012. The patients were 3 men and 2 women with a mean age of 60 ± 11 years (range 46-68 years). They had old myocardial infarction and unstable angina, aortic and mitral stenosis, left arterial myxoma, aortic stenosis, and native valve endocarditis followed by prosthetic valve endocarditis. Operative procedures included coronary artery bypass grafting, double-valve replacement, resection of left arterial myxoma, 2 aortic valve replacements, and a double-valve replacement. Renal protection consisted of steroid cover (hydrocortisone 100-500 mg or methylprednisolone 1000 mg) and intravenous immunosuppressant infusion (cyclosporine 30-40 mg day(-1) or tacrolimus 1.0 mg day(-1)).

Results: 5 cases were uneventful and good renal graft function was maintained at discharge (serum creatinine 2.1 ± 0.5 mg dL(-1)). There was one operative death after emergency double-valve replacement for methicillin-resistant Staphylococcus aureus-associated prosthetic valve endocarditis. Although the endocarditis improved after valve replacement, the patient died of postoperative pneumonia on postoperative day 45.

Conclusions: careful perioperative management can allow successful open heart surgery after renal transplantation. However, severe complications, especially methicillin-resistant Staphylococcus aureus infection, may cause renal graft loss.

Keywords: Coronary artery bypass grafting; Coronary disease; Heart valve diseases; Japan; Kidney transplantation.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Coronary Artery Bypass* / adverse effects
  • Coronary Artery Bypass* / mortality
  • Drug Therapy, Combination
  • Female
  • Graft Survival / drug effects
  • Heart Diseases / microbiology
  • Heart Diseases / mortality
  • Heart Diseases / surgery*
  • Heart Valve Prosthesis Implantation* / adverse effects
  • Heart Valve Prosthesis Implantation* / mortality
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Japan
  • Kidney Transplantation* / adverse effects
  • Kidney Transplantation* / mortality
  • Male
  • Methicillin-Resistant Staphylococcus aureus / pathogenicity
  • Middle Aged
  • Reoperation
  • Risk Factors
  • Surgical Wound Infection / microbiology
  • Surgical Wound Infection / prevention & control
  • Time Factors
  • Treatment Outcome

Substances

  • Immunosuppressive Agents